---

Remdesivir (RNA Polymerase inhibtor)
Estimated Study Start Date : February 5, 2020
Estimated Primary Completion Date : April 3, 2020 (Severe)
Estimated Primary Completion Date : April 10, 2020 (Mild/Moderate)
Estimated Study Completion Date : April 27, 2020

ASC09F、Ritonavir (HIV用藥，Protease Inhibitors)與Oseltamivir (克流感)
Estimated Study Start Date : February 1, 2020
Estimated Primary Completion Date : May 1, 2020
Estimated Study Completion Date : July 1, 2020

Darunavir and Cobicistat (HIV用藥，Protease Inhibitors)
Estimated Study Start Date : January 30, 2020
Estimated Primary Completion Date : August 31, 2020
Estimated Study Completion Date : December 31, 2020

Hydroxychloroquine (奎寧)
Estimated Study Start Date : February 6, 2020
Estimated Primary Completion Date : August 31, 2020
Estimated Study Completion Date : December 31, 2020

Arbidol (流感藥物，阻止病毒進入細胞)
Estimated Study Start Date : February 7, 2020
Estimated Primary Completion Date : July 1, 2020
Estimated Study Completion Date : December 30, 2020

Arbidol與Interferon (干擾素)
Estimated Study Start Date : February 1, 2020
Estimated Primary Completion Date : June 1, 2020
Estimated Study Completion Date : July 1, 2020

Abidol、Oseltamivir、Lopinavir/ritonavir (HIV用藥，Protease Inhibitors)
Estimated Study Start Date : February 1, 2020
Estimated Primary Completion Date : June 1, 2020
Estimated Study Completion Date : July 1, 2020

IVIG (Severe cases)
Estimated Study Start Date : February 10, 2020
Estimated Primary Completion Date : April 30, 2020
Estimated Study Completion Date : June 30, 2020

Methylprednisolone (Severe cases)
Actual Study Start Date : January 26, 2020
Estimated Primary Completion Date : April 25, 2020
Estimated Study Completion Date : December 25, 2020

資料來源：https://clinicaltrials.gov/ct2/home



--
※ 發信站: 批踢踢實業坊(ptt.cc), 來自: 223.137.83.46 (臺灣)
※ 文章代碼(AID): #1UG4gxM8 (nCoV2019)
※ 文章網址: https://www.ptt.cc/bbs/nCoV2019/M.1581271739.A.588.html